NEWS

Three organs are still not a crowd, as the NanoSanguis SA perfusionist team jokes

In addition to the kidneys and liver, the innovative NanOx system also works well in heart perfusion, as proven by a recent study conducted in collaboration with the Dr. n. med. Piotr Kolsut , Head of the Department of Cardiothoracic Surgery and Transplantation at the National Institute of Cardiology named after him. Stefan Cardinal Wyszynski.

The Polish company NanoGroup, or more precisely its subsidiary NanoSanguis, has successfully performed a 4-hour heart perfusion using the NanOx system under development. The organ was harvested in a DBD model and perfused under normothermic conditions with NanOx fluid after attachment.

Thanks to the clever design of the device, it was possible to defibrillate with cardiac spoons during perfusion without damaging the components of the apparatus, and to read the ECG.

Analysis of perfusion parameters and tissue damage markers showed a reconditioning effect of the NanOx system on the organ lasting for 2 hours, while an increase in vascular flow resistance was observed during the following two hours.

Throughout the perfusion process, oxygen consumption remains at a constant, satisfactorily high level.

The need to achieve better perfusion parameters and biochemical analysis results, as well as the positive evaluation of the NanOx system by a prominent specialist, dr. n. med. Piotr Kolsut motivate the company to continue working and improving the device and the fluid.

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.